242 related articles for article (PubMed ID: 20498839)
1. Persistence of West Nile virus in the central nervous system and periphery of mice.
Appler KK; Brown AN; Stewart BS; Behr MJ; Demarest VL; Wong SJ; Bernard KA
PLoS One; 2010 May; 5(5):e10649. PubMed ID: 20498839
[TBL] [Abstract][Full Text] [Related]
2. Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.
Stewart BS; Demarest VL; Wong SJ; Green S; Bernard KA
BMC Immunol; 2011 Jan; 12():6. PubMed ID: 21251256
[TBL] [Abstract][Full Text] [Related]
3. Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice.
Hunsperger EA; Roehrig JT
J Neurovirol; 2009 May; 15(3):211-8. PubMed ID: 19444694
[TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppression on West Nile virus infection in hamsters.
Mateo R; Xiao SY; Guzman H; Lei H; Da Rosa AP; Tesh RB
Am J Trop Med Hyg; 2006 Aug; 75(2):356-62. PubMed ID: 16896148
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus: immunity and pathogenesis.
Lim SM; Koraka P; Osterhaus AD; Martina BE
Viruses; 2011 Jun; 3(6):811-28. PubMed ID: 21994755
[TBL] [Abstract][Full Text] [Related]
6. A hamster-derived West Nile virus isolate induces persistent renal infection in mice.
Saxena V; Xie G; Li B; Farris T; Welte T; Gong B; Boor P; Wu P; Tang SJ; Tesh R; Wang T
PLoS Negl Trop Dis; 2013; 7(6):e2275. PubMed ID: 23785537
[TBL] [Abstract][Full Text] [Related]
7. STING is required for host defense against neuropathological West Nile virus infection.
McGuckin Wuertz K; Treuting PM; Hemann EA; Esser-Nobis K; Snyder AG; Graham JB; Daniels BP; Wilkins C; Snyder JM; Voss KM; Oberst A; Lund J; Gale M
PLoS Pathog; 2019 Aug; 15(8):e1007899. PubMed ID: 31415679
[TBL] [Abstract][Full Text] [Related]
8. IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection.
Ramos HJ; Lanteri MC; Blahnik G; Negash A; Suthar MS; Brassil MM; Sodhi K; Treuting PM; Busch MP; Norris PJ; Gale M
PLoS Pathog; 2012; 8(11):e1003039. PubMed ID: 23209411
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
[TBL] [Abstract][Full Text] [Related]
11. West Nile Virus spread and differential chemokine response in the central nervous system of mice: Role in pathogenic mechanisms of encephalitis.
Vidaña B; Johnson N; Fooks AR; Sánchez-Cordón PJ; Hicks DJ; Nuñez A
Transbound Emerg Dis; 2020 Mar; 67(2):799-810. PubMed ID: 31655004
[TBL] [Abstract][Full Text] [Related]
12. Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis.
Bardina SV; Brown JA; Michlmayr D; Hoffman KW; Sum J; Pletnev AG; Lira SA; Lim JK
J Virol; 2017 May; 91(10):. PubMed ID: 28356527
[TBL] [Abstract][Full Text] [Related]
13. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Gorman MJ; Poddar S; Farzan M; Diamond MS
J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
[TBL] [Abstract][Full Text] [Related]
14. Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus.
Kumar M; Roe K; Nerurkar PV; Namekar M; Orillo B; Verma S; Nerurkar VR
PLoS One; 2012; 7(8):e44682. PubMed ID: 22953001
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a mouse model for the West Nile virus group for the purpose of determining viral pathotypes.
Bingham J; Payne J; Harper J; Frazer L; Eastwood S; Wilson S; Lowther S; Lunt R; Warner S; Carr M; Hall RA; Durr PA
J Gen Virol; 2014 Jun; 95(Pt 6):1221-1232. PubMed ID: 24694397
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Granulocyte-Macrophage Colony-Stimulating Factor Reduces Viral Titers in the Brains of West Nile Virus-Infected Mice and Improves Survival.
Stonedahl S; Leser JS; Clarke P; Potter H; Boyd TD; Tyler KL
J Virol; 2023 Mar; 97(3):e0180522. PubMed ID: 36802227
[TBL] [Abstract][Full Text] [Related]
17. Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.
Hunsperger EA; Roehrig JT
J Neurovirol; 2006 Apr; 12(2):129-39. PubMed ID: 16798674
[TBL] [Abstract][Full Text] [Related]
18. Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system.
Lazear HM; Pinto AK; Ramos HJ; Vick SC; Shrestha B; Suthar MS; Gale M; Diamond MS
J Virol; 2013 Nov; 87(21):11401-15. PubMed ID: 23966390
[TBL] [Abstract][Full Text] [Related]
19. [Meningoencephalitis caused by West Nile virus in a renal transplant recipient].
Ertilav M; Ozkul A; Zeytinoğlu A; Sen S; Sipahi S; Töz H; Kitiş O; Eraslan C
Mikrobiyol Bul; 2014 Oct; 48(4):674-82. PubMed ID: 25492663
[TBL] [Abstract][Full Text] [Related]
20. Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain.
Kumar M; Roe K; O'Connell M; Nerurkar VR
J Neuroinflammation; 2015 Sep; 12():178. PubMed ID: 26392176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
